nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—Danazol—Hydrocortisone—atopic dermatitis	0.157	0.159	CrCrCtD
Trilostane—Danazol—Prednisone—atopic dermatitis	0.135	0.137	CrCrCtD
Trilostane—Progesterone—Hydrocortisone—atopic dermatitis	0.115	0.116	CrCrCtD
Trilostane—Methyltestosterone—Hydrocortisone—atopic dermatitis	0.112	0.113	CrCrCtD
Trilostane—Testosterone—Hydrocortisone—atopic dermatitis	0.0999	0.101	CrCrCtD
Trilostane—Progesterone—Prednisolone—atopic dermatitis	0.0967	0.0976	CrCrCtD
Trilostane—Methyltestosterone—Prednisone—atopic dermatitis	0.0966	0.0975	CrCrCtD
Trilostane—Methyltestosterone—Prednisolone—atopic dermatitis	0.0943	0.0951	CrCrCtD
Trilostane—Testosterone—Prednisolone—atopic dermatitis	0.0839	0.0847	CrCrCtD
Trilostane—HSD3B1—skin of body—atopic dermatitis	0.00356	0.404	CbGeAlD
Trilostane—HSD3B2—head—atopic dermatitis	0.00184	0.209	CbGeAlD
Trilostane—ESR2—neck—atopic dermatitis	0.00142	0.161	CbGeAlD
Trilostane—ESR1—neck—atopic dermatitis	0.000973	0.111	CbGeAlD
Trilostane—ESR2—head—atopic dermatitis	0.0006	0.0682	CbGeAlD
Trilostane—ESR1—head—atopic dermatitis	0.000411	0.0467	CbGeAlD
Trilostane—HSD3B1—Corticotropin-releasing hormone—IL18—atopic dermatitis	2.31e-05	0.0578	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—NFKBIA—atopic dermatitis	1.76e-05	0.0441	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—IL18—atopic dermatitis	1.75e-05	0.0438	CbGpPWpGaD
Trilostane—ESR1—Estrogen Receptor Pathway—PPARA—atopic dermatitis	1.65e-05	0.0414	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.43e-05	0.0358	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptors—PPARA—atopic dermatitis	1.39e-05	0.0348	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—NFKBIA—atopic dermatitis	1.34e-05	0.0335	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—CXCL8—atopic dermatitis	1.26e-05	0.0315	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—IL2—atopic dermatitis	1.2e-05	0.0301	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—MAPK8—atopic dermatitis	1.11e-05	0.0277	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	1.1e-05	0.0275	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.08e-05	0.0271	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—SELE—atopic dermatitis	1.03e-05	0.0257	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—CXCL8—atopic dermatitis	9.54e-06	0.0239	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—IL2—atopic dermatitis	9.12e-06	0.0228	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—MAPK8—atopic dermatitis	8.39e-06	0.021	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL13—atopic dermatitis	8.29e-06	0.0207	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	7.63e-06	0.0191	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—PPARA—atopic dermatitis	7.02e-06	0.0176	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL5—atopic dermatitis	6.79e-06	0.017	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GLB1—atopic dermatitis	6.38e-06	0.0159	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ADSL—atopic dermatitis	6.11e-06	0.0153	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—IL5—atopic dermatitis	6.04e-06	0.0151	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	5.54e-06	0.0139	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	5.43e-06	0.0136	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL10—atopic dermatitis	5.18e-06	0.013	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL10—atopic dermatitis	4.96e-06	0.0124	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GLB1—atopic dermatitis	4.83e-06	0.0121	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL4—atopic dermatitis	4.83e-06	0.0121	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—NGF—atopic dermatitis	4.82e-06	0.0121	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.65e-06	0.0116	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ADSL—atopic dermatitis	4.63e-06	0.0116	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	4.62e-06	0.0116	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—atopic dermatitis	4.42e-06	0.011	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.52e-06	0.00881	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.38e-06	0.00846	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IFNG—atopic dermatitis	3.35e-06	0.00837	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—CXCL8—atopic dermatitis	3.11e-06	0.00778	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.05e-06	0.00763	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—IFNG—atopic dermatitis	2.99e-06	0.00747	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IFNG—atopic dermatitis	2.92e-06	0.0073	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	2.83e-06	0.00709	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—MAPK8—atopic dermatitis	2.74e-06	0.00685	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	2.72e-06	0.0068	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CXCL8—atopic dermatitis	2.71e-06	0.00679	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—IL2—atopic dermatitis	2.65e-06	0.00664	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	2.64e-06	0.00661	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL2—atopic dermatitis	2.59e-06	0.00649	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—IL1B—atopic dermatitis	2.46e-06	0.00616	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	2.33e-06	0.00583	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—MAPK8—atopic dermatitis	2.26e-06	0.00565	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.12e-06	0.00531	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPARA—atopic dermatitis	2.07e-06	0.00518	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	1.97e-06	0.00494	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PPARA—atopic dermatitis	1.9e-06	0.00475	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	1.86e-06	0.00464	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IL6—atopic dermatitis	1.75e-06	0.00437	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	1.7e-06	0.00426	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.68e-06	0.0042	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.59e-06	0.00398	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPARA—atopic dermatitis	1.57e-06	0.00392	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	1.54e-06	0.00385	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL6—atopic dermatitis	1.52e-06	0.00381	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—FCER2—atopic dermatitis	1.17e-06	0.00292	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL22—atopic dermatitis	1.09e-06	0.00272	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.07e-06	0.00268	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL27—atopic dermatitis	9.68e-07	0.00242	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PPARA—atopic dermatitis	9.58e-07	0.0024	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PPARA—atopic dermatitis	9.14e-07	0.00229	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL17—atopic dermatitis	8.68e-07	0.00217	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	8.46e-07	0.00212	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IL6—atopic dermatitis	8.2e-07	0.00205	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—KIF3A—atopic dermatitis	7.74e-07	0.00194	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL11—atopic dermatitis	7e-07	0.00175	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CMA1—atopic dermatitis	7e-07	0.00175	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—STAT6—atopic dermatitis	6.58e-07	0.00165	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCR3—atopic dermatitis	5.71e-07	0.00143	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NPS—atopic dermatitis	5.09e-07	0.00127	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TAC1—atopic dermatitis	5.09e-07	0.00127	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CXCR3—atopic dermatitis	4.99e-07	0.00125	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL5—atopic dermatitis	4.73e-07	0.00118	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PPARA—atopic dermatitis	4.61e-07	0.00115	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CXCL10—atopic dermatitis	4.03e-07	0.00101	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL5—atopic dermatitis	3.47e-07	0.000868	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NGF—atopic dermatitis	3.21e-07	0.000804	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCR5—atopic dermatitis	3.13e-07	0.000782	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NFKBIA—atopic dermatitis	2.65e-07	0.000663	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CXCL8—atopic dermatitis	1.89e-07	0.000473	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL2—atopic dermatitis	1.81e-07	0.000452	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MAPK8—atopic dermatitis	1.66e-07	0.000416	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL6—atopic dermatitis	1.06e-07	0.000266	CbGpPWpGaD
